Titre : Résultat thérapeutique

Résultat thérapeutique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Young Adult
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Résultat thérapeutique : Questions médicales les plus fréquentes", "headline": "Résultat thérapeutique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Résultat thérapeutique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-09", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Résultat thérapeutique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Évaluation de résultat (soins)", "url": "https://questionsmedicales.fr/mesh/D017063", "about": { "@type": "MedicalCondition", "name": "Évaluation de résultat (soins)", "code": { "@type": "MedicalCode", "code": "D017063", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Arrêt précoce d'essais cliniques", "alternateName": "Early Termination of Clinical Trials", "url": "https://questionsmedicales.fr/mesh/D057239", "about": { "@type": "MedicalCondition", "name": "Arrêt précoce d'essais cliniques", "code": { "@type": "MedicalCode", "code": "D057239", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.379" } } }, { "@type": "MedicalWebPage", "name": "Évaluation de la réponse des tumeurs solides aux traitements", "alternateName": "Response Evaluation Criteria in Solid Tumors", "url": "https://questionsmedicales.fr/mesh/D066066", "about": { "@type": "MedicalCondition", "name": "Évaluation de la réponse des tumeurs solides aux traitements", "code": { "@type": "MedicalCode", "code": "D066066", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.569" } } }, { "@type": "MedicalWebPage", "name": "Réponse virologique soutenue", "alternateName": "Sustained Virologic Response", "url": "https://questionsmedicales.fr/mesh/D000072230", "about": { "@type": "MedicalCondition", "name": "Réponse virologique soutenue", "code": { "@type": "MedicalCode", "code": "D000072230", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.665" } } }, { "@type": "MedicalWebPage", "name": "Index thérapeutique", "alternateName": "Therapeutic Index", "url": "https://questionsmedicales.fr/mesh/D000076162", "about": { "@type": "MedicalCondition", "name": "Index thérapeutique", "code": { "@type": "MedicalCode", "code": "D000076162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.713" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Index thérapeutique du médicament", "alternateName": "Therapeutic Index, Drug", "url": "https://questionsmedicales.fr/mesh/D000074389", "about": { "@type": "MedicalCondition", "name": "Index thérapeutique du médicament", "code": { "@type": "MedicalCode", "code": "D000074389", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.713.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Échec thérapeutique", "alternateName": "Treatment Failure", "url": "https://questionsmedicales.fr/mesh/D017211", "about": { "@type": "MedicalCondition", "name": "Échec thérapeutique", "code": { "@type": "MedicalCode", "code": "D017211", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.760" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Échec des secours (soins de santé)", "alternateName": "Failure to Rescue, Health Care", "url": "https://questionsmedicales.fr/mesh/D000067248", "about": { "@type": "MedicalCondition", "name": "Échec des secours (soins de santé)", "code": { "@type": "MedicalCode", "code": "D000067248", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.715.360.575.575.800.760.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Résultat thérapeutique", "alternateName": "Treatment Outcome", "code": { "@type": "MedicalCode", "code": "D016896", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Peter S Rose", "url": "https://questionsmedicales.fr/author/Peter%20S%20Rose", "affiliation": { "@type": "Organization", "name": "Clinic Department of Orthopedic Surgery, Rochester, Minnesota, USA." } }, { "@type": "Person", "name": "Matthew T Houdek", "url": "https://questionsmedicales.fr/author/Matthew%20T%20Houdek", "affiliation": { "@type": "Organization", "name": "Clinic Department of Orthopedic Surgery, Rochester, Minnesota, USA." } }, { "@type": "Person", "name": "Pim B Olthof", "url": "https://questionsmedicales.fr/author/Pim%20B%20Olthof", "affiliation": { "@type": "Organization", "name": "Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: p.olthof@erasmusmc.nl." } }, { "@type": "Person", "name": "Stijn Franssen", "url": "https://questionsmedicales.fr/author/Stijn%20Franssen", "affiliation": { "@type": "Organization", "name": "Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Myeloproliferative neoplasms in adolescents and young adults.", "datePublished": "2022-08-14", "url": "https://questionsmedicales.fr/article/36333071", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.beha.2022.101374" } }, { "@type": "ScholarlyArticle", "name": "Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.", "datePublished": "2022-05-19", "url": "https://questionsmedicales.fr/article/35521712", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1530/EJE-21-1104" } }, { "@type": "ScholarlyArticle", "name": "Adolescent and Young Adult Communication Preferences.", "datePublished": "2022-11-16", "url": "https://questionsmedicales.fr/article/36383117", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1089/jayao.2022.0087" } }, { "@type": "ScholarlyArticle", "name": "Thoughts of young adults with Down syndrome.", "datePublished": "2022-07-09", "url": "https://questionsmedicales.fr/article/36428048", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.apnu.2022.06.006" } }, { "@type": "ScholarlyArticle", "name": "Adrenal crises in adolescents and young adults.", "datePublished": "2022-05-18", "url": "https://questionsmedicales.fr/article/35583847", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12020-022-03070-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Qualité, accès, évaluation des soins de santé", "item": "https://questionsmedicales.fr/mesh/D017530" }, { "@type": "ListItem", "position": 3, "name": "Qualité des soins de santé", "item": "https://questionsmedicales.fr/mesh/D011787" }, { "@type": "ListItem", "position": 4, "name": "Mécanismes d'évaluation des soins de santé", "item": "https://questionsmedicales.fr/mesh/D017531" }, { "@type": "ListItem", "position": 5, "name": "Évaluation des résultats et des processus en soins de santé", "item": "https://questionsmedicales.fr/mesh/D010043" }, { "@type": "ListItem", "position": 6, "name": "Évaluation de résultat (soins)", "item": "https://questionsmedicales.fr/mesh/D017063" }, { "@type": "ListItem", "position": 7, "name": "Résultat thérapeutique", "item": "https://questionsmedicales.fr/mesh/D016896" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Résultat thérapeutique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Résultat thérapeutique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Résultat thérapeutique", "description": "Comment évaluer l'efficacité d'un traitement ?\nQuels outils mesurent les résultats thérapeutiques ?\nQu'est-ce qu'un critère de jugement ?\nComment les résultats sont-ils rapportés ?\nQuelle est l'importance des études de suivi ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Young+Adult&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Résultat thérapeutique", "description": "Quels symptômes indiquent un bon résultat thérapeutique ?\nComment les symptômes peuvent-ils masquer les résultats ?\nLes symptômes peuvent-ils réapparaître après un traitement ?\nComment les symptômes influencent-ils le traitement ?\nQuels sont les symptômes d'une réponse négative au traitement ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Young+Adult&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Résultat thérapeutique", "description": "Comment prévenir les échecs thérapeutiques ?\nQuel rôle joue l'éducation du patient ?\nLes vaccinations influencent-elles les résultats ?\nComment le mode de vie affecte-t-il les résultats ?\nQuelles sont les stratégies de prévention des complications ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Young+Adult&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Résultat thérapeutique", "description": "Quels traitements montrent de bons résultats ?\nComment personnaliser un traitement pour de meilleurs résultats ?\nQuel rôle joue l'adhésion au traitement ?\nLes traitements alternatifs sont-ils efficaces ?\nComment évaluer les effets secondaires des traitements ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Young+Adult&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Résultat thérapeutique", "description": "Quelles complications peuvent survenir après un traitement ?\nComment évaluer les complications d'un traitement ?\nLes complications affectent-elles les résultats ?\nComment prévenir les complications liées au traitement ?\nQuelles sont les complications à long terme des traitements ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Young+Adult&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Résultat thérapeutique", "description": "Quels facteurs de risque influencent les résultats ?\nComment les comorbidités affectent-elles les résultats ?\nLe mode de vie influence-t-il les résultats ?\nComment l'âge impacte-t-il les résultats ?\nLes facteurs psychologiques influencent-ils les résultats ?", "url": "https://questionsmedicales.fr/mesh/D016896?mesh_terms=Young+Adult&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'efficacité d'un traitement ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité se mesure par l'amélioration des symptômes et des résultats cliniques." } }, { "@type": "Question", "name": "Quels outils mesurent les résultats thérapeutiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des échelles de mesure, des questionnaires et des biomarqueurs sont utilisés." } }, { "@type": "Question", "name": "Qu'est-ce qu'un critère de jugement ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "C'est un indicateur utilisé pour évaluer l'efficacité d'un traitement dans les études cliniques." } }, { "@type": "Question", "name": "Comment les résultats sont-ils rapportés ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les résultats sont souvent rapportés sous forme de pourcentages d'amélioration ou de scores." } }, { "@type": "Question", "name": "Quelle est l'importance des études de suivi ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'évaluer la durabilité des résultats thérapeutiques sur le long terme." } }, { "@type": "Question", "name": "Quels symptômes indiquent un bon résultat thérapeutique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une réduction des symptômes, comme la douleur ou la fatigue, indique un bon résultat." } }, { "@type": "Question", "name": "Comment les symptômes peuvent-ils masquer les résultats ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes persistants peuvent donner l'impression d'un traitement inefficace, même si des améliorations sont présentes." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils réapparaître après un traitement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains symptômes peuvent réapparaître, nécessitant une réévaluation du traitement." } }, { "@type": "Question", "name": "Comment les symptômes influencent-ils le traitement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes guident les ajustements de traitement pour optimiser les résultats." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une réponse négative au traitement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une aggravation des symptômes ou l'apparition de nouveaux symptômes peuvent indiquer une réponse négative." } }, { "@type": "Question", "name": "Comment prévenir les échecs thérapeutiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation régulière et des ajustements de traitement peuvent prévenir les échecs." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation du patient ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation aide les patients à comprendre leur traitement et à améliorer leur adhésion." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles les résultats ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations peuvent prévenir des complications et améliorer les résultats globaux." } }, { "@type": "Question", "name": "Comment le mode de vie affecte-t-il les résultats ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut améliorer les résultats thérapeutiques en renforçant la santé globale." } }, { "@type": "Question", "name": "Quelles sont les stratégies de prévention des complications ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les stratégies incluent le suivi régulier, l'éducation et l'adaptation des traitements." } }, { "@type": "Question", "name": "Quels traitements montrent de bons résultats ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements basés sur des preuves, comme les médicaments et la thérapie physique, montrent souvent de bons résultats." } }, { "@type": "Question", "name": "Comment personnaliser un traitement pour de meilleurs résultats ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La personnalisation se fait en tenant compte des caractéristiques individuelles du patient et de sa réponse au traitement." } }, { "@type": "Question", "name": "Quel rôle joue l'adhésion au traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne adhésion au traitement est cruciale pour atteindre des résultats thérapeutiques optimaux." } }, { "@type": "Question", "name": "Les traitements alternatifs sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements alternatifs peuvent être efficaces, mais leur efficacité doit être évaluée scientifiquement." } }, { "@type": "Question", "name": "Comment évaluer les effets secondaires des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires sont évalués par des rapports de patients et des études cliniques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après un traitement ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des infections ou des effets secondaires peuvent survenir après un traitement." } }, { "@type": "Question", "name": "Comment évaluer les complications d'un traitement ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont évaluées par des examens cliniques et des rapports de patients." } }, { "@type": "Question", "name": "Les complications affectent-elles les résultats ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent altérer les résultats thérapeutiques et nécessiter des ajustements." } }, { "@type": "Question", "name": "Comment prévenir les complications liées au traitement ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par un suivi régulier et une gestion proactive des effets secondaires." } }, { "@type": "Question", "name": "Quelles sont les complications à long terme des traitements ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent persister, comme des douleurs chroniques ou des troubles fonctionnels." } }, { "@type": "Question", "name": "Quels facteurs de risque influencent les résultats ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge, le sexe et les comorbidités peuvent influencer les résultats thérapeutiques." } }, { "@type": "Question", "name": "Comment les comorbidités affectent-elles les résultats ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les comorbidités peuvent compliquer le traitement et altérer les résultats globaux." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il les résultats ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de vie saines peuvent améliorer les résultats thérapeutiques." } }, { "@type": "Question", "name": "Comment l'âge impacte-t-il les résultats ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "L'âge peut affecter la réponse au traitement et la tolérance aux effets secondaires." } }, { "@type": "Question", "name": "Les facteurs psychologiques influencent-ils les résultats ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme le stress et l'anxiété peuvent affecter l'adhésion et les résultats thérapeutiques." } } ] } ] }

Sources (10000 au total)

Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.

Mild to moderate hypertriglyceridemia is a condition often associated with obesity and diabetes, with as yet incomplete knowledge of underlying genetic architecture. The 22q11.2 microdeletion is assoc... This was a cohort study comparing 6793 population-based adults and 267 with a 22q11.2 microdeletion aged 17-69 years, excluding those with diabetes or on statins.... We used binomial logistic regression modeling to identify predictors of hypertriglyceridemia, accounting for the 22q11.2 microdeletion, male sex, BMI, ethnicity, age, and antipsychotic medications.... The 22q11.2 microdeletion was a significant independent predictor of mild to moderate hypertriglyceridemia (odds ratio (OR): 2.35, 95% CI: 1.70-3.26). All other factors examined were also significant ... The 22q11.2 microdeletion is associated with hypertriglyceridemia even when accounting for other known risk factors for elevated triglycerides. This effect is seen in young adulthood (76.6% were <40 y...

Thoughts of young adults with Down syndrome.

This study aimed to obtain information about the thoughts of young adults with Down syndrome through interviews of them.... The numbers of participants were 4 and 7 in order to group interviews and individual interviews. They were recruited through the local Association of Parents of Down syndrome. The study incorporated a... Through analysis, six themes emerged: 1) thoughts about work, 2) existence of friends, 3) how to spend leisure time, 4) meaning of disability, 5) relationships with people, and 6) future dreams.... 1) Although young adults with Down syndrome are serious about their work, it is difficult for them to make friends at work. However, they recognized people at work as their comrades and were encourage...

Adrenal crises in adolescents and young adults.

Review the literature concerning adrenal insufficiency (AI) and adrenal crisis (AC) in adolescents and young adults.... Searches of PubMed identifying relevant reports up to March 2022.... AI is rare disorder that requires lifelong glucocorticoid replacement therapy and is associated with substantial morbidity and occasional mortality among adolescents and young adults. Aetiologies in t... In this review, we examine the current state of knowledge of AC epidemiology in emerging adults; examine the causes of ACs in this age group; and suggest areas for further investigation that are aimed...

Ischemic Stroke in Young Tunisian Adults.

Ischemic Stroke in young adults is a real public health problem; it's a major cause of disability, alters quality of life and has a great socio-economic impact.... determine risk factors and specify the etiology of arterial ischemic stroke in young Tunisian adults.... In this 5 years retrospective study (2015-2020), we included all young adults (18-50 years) admitted for arterial ischemic stroke (AIS). Risk factors were registered and analyzed. All patients were in... We collected 200 patients with AIS. The mean age was 41.37 years ± 6.99. Traditional vascular risk factors were observed in more than 1⁄4 patients. A definite cause of stroke was identified in 120 pat... Through this study, we demonstrated the diversity of etiology of stroke in young Tunisian adults. Changes of lifestyle are responsible for the occurrence of the traditional risk factors at an early ag...

Primary Hyperparathyroidism in Young Adult Patients.

Primary hyperparathyroidism (PHPT) affects 2% of Americans over 55 years of age, and is less common in younger patients. Pediatric PHPT patients have higher rates of multigland disease (MGD). We studi... Retrospective chart review was performed on patients who underwent parathyroidectomy for PHPT (2000-2019). Cohorts were defined by age: Group A (18-40 years) and Group B (> 40 years). Univariate and m... Of 3889 patients with PHPT, 9.1% (n = 352) were included in Group A. On multivariate analysis, multiple endocrine neoplasia (odds ratio [OR] 6.3, 95% confidence interval [CI] 3.1-12.7), male sex (OR 1... In our population of patients with sporadic PHPT, a positive family history of PHPT was strongly associated with MGD; additional associations were found with prior parathyroidectomy, non-localizing im...